NIH-funded research R01 grant

Using nicotinamide riboside to lower blood pressure and improve artery health in older adults

Official title: Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults

Funded at University of Colorado · NIH-10539289 · Data updated 2026-11-12

This study is looking at whether taking nicotinamide riboside can help lower high blood pressure and improve blood vessel health in middle-aged and older adults, offering a friendly option for those who might find lifestyle changes challenging.

More Blood Pressure research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado
NIH-funded
Lab location1 site (Boulder, UNITED STATES)
Project startFebruary 1, 2019
Project endNovember 30, 2025
Funding year2023
Award (this year)$437,530
NIH project number5R01AG061514-05
Project IDNIH-10539289 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are middle-aged and older adults experiencing elevated systolic blood pressure.

Less likely to help

Patients under 21 years old or those with normal blood pressure levels may not benefit from this research.

What this research studies

This research investigates the effects of nicotinamide riboside supplementation on reducing elevated systolic blood pressure and improving arterial stiffness in middle-aged and older adults. The study aims to understand how this supplement can enhance the body's ability to produce NAD+, a molecule that plays a crucial role in cellular health and function. By focusing on older adults, the research seeks to provide a potential alternative to traditional lifestyle changes that may be difficult for this population to maintain. Participants will be monitored for changes in blood pressure and arterial health over the course of the study.

Why it matters

Potential benefit: If successful, this research could provide a new, effective treatment option for managing high blood pressure and improving cardiovascular health in older adults.

How similar studies have gone: Previous research has shown promising results with NAD+ boosting strategies in animal models, indicating potential for success in human applications.

Where this research is happening

  • University of Colorado
    Boulder, United States
    Active

Researchers

  • Principal investigator: Seals, Douglas R — University of Colorado
  • Study coordinator: Seals, Douglas R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.